Financings in Brief: Lifecell:
This article was originally published in The Gray Sheet
Executive Summary
Lifecell: Completes private offering of convertible preferred stock and common stock warrants, expected to generate $12.4 mil. for The Woodlands, Texas-based developer of the AlloDerm tissue graft. Lifecell sold series B preferred stock convertible to common stock at a price of $3.10 per share and warrants for common stock exercisable at $4.13 per share. The offering was made to institutional and other investors...